MEN2 was initially separated into three syndromes: MEN2A (95% of MEN2), MEN2B (also called MEN3), and familial medullary thyroid carcinoma (FMTC), due to very specific clinical presentations that depend on the mutations present. Here, RET is linked to multiple endocrine neoplasia type 2.